CBS 2019
CBSMD教育中心
中 文

动脉粥样硬化性心血管疾病预防

Abstract

Recommended Article

Association of Statin Use With All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus Simple Electrocardiographic Measures Improve Sudden Arrhythmic Death Prediction in Coronary Disease The Use of Sex-Specific Factors in the Assessment of Women’s Cardiovascular Risk From Focal Lipid Storage to Systemic Inflammation From Detecting the Vulnerable Plaque to Managing the Vulnerable Patient Coronary calcification in the diagnosis of coronary artery disease Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors: JACC Focus Seminar

LetterJune 2, 2020 Vol 141, Issue 22

JOURNAL:Circulation. Article Link

Lipoprotein(a) in Alzheimer, Atherosclerotic, Cerebrovascular, Thrombotic, and Valvular Disease: Mendelian Randomization Investigation

SC Larsson, D Gill , AM Mason et al. Keywords: Lipoprotein(a); causal effect; CAD; valvular disease

Full Text PDF